ReLive's
Blood & Organ Banks · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
303 Wyman St Ste 270, Waltham, Massachus...Website
www.relivebio.comRevenue
<$5 MillionIndustry
About ReLive's
ReLive's Org Chart
Is ReLive's your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on ReLive's recently announced quarterly report
Funding: Get notified immidiatlly once ReLive's has new funding data
Product Launch: Get notified when ReLive's launches new products
Congratulate Masked Content for being promoted to Masked Content at ReLive's
Check out if ReLive's is spiking on competitors!
ReLive's, which may be a good buyer, showed buying intent in Masked Content Topic
Check if ReLive's has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if ReLive's had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at ReLive's
Find more new buyers
Company Profile Activity
Activity Insights
ReLive's is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
ReLive's is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about ReLive's.
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ReLive's
ReLive Life Sciences specializes in pioneering orthopedic regenerative cell therapies aimed at treating cartilage reconstruction and joint cartilage defects. The company focuses on personalized autologous cell therapies for athletes and patients with cartilage injuries, boasting over 25 years of experience in tissue engineering. With more than 200... Read More